Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia

    March 2020 in “ Dermatologic Surgery
    Xuesong Zhang, Dongmei Zhou, Tengfei Ma, Qingquan Liu
    Image of study
    TLDR A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.
    In a 2020 study involving 15 male patients with Androgenic Alopecia (AGA), researchers found that Vascular Endothelial Growth Factor (VEGF) can protect CD200-rich and CD34-positive hair follicle stem cells (HFSCs) from androgen-induced apoptosis via the PI3K/Akt pathway. The protective effect of VEGF was dose-dependent, with the most effective dose being 200 ng/mL. The study suggested that using VEGF to protect these specific HFSCs could be a potential new therapeutic strategy for AGA.
    View this study on journals.lww.com →

    Cited in this study

    13 / results